Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial)

Thrombosis Research

Volumn 101, Issue 6, 2001, Pages 427-433

  Serebruany, Victor L ^b   Alford, Amanda B ^a   Meister, Andrew F ^a   Fuzaylov, Sergey Y ^a   Gattis, Wendy A ^a   Gurbel, Paul A ^a   O'Connor, Christopher M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

Analyzers; Congestive heart failure; Platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PADGEM PROTEIN; RECEPTOR PROTEIN; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTPATIENT; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL; THROMBOCYTE ADHESION; THROMBOCYTE ADHESIVENESS; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; AGED; ASPIRIN; BLOOD COAGULATION; COLLAGEN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POINT-OF-CARE SYSTEMS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STRESS, MECHANICAL;

EID: 0035868302     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00431-X     Document Type: Article

References (25)

1. Guidelines for the evaluation and management of heart failure
2. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
3. Warfarin anticoagulation and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
4. Antiplatelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
5. Platelet function studies in heart disease: VI. Enhanced platelet aggregate formation activity in congestive heart failure: Inhibition by sodium nitroprusside
6. Platelet function, thrombin and fibrinolytic activity in patients with heart failure
7. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure
8. Altered platelet function in patients with severe congestive heart failure
9. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure
10. Increased soluble platelet/endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy
11. The coagulation system is activated in idiopathic cardiomyopathy
12. Simulation of primary hemostasis in vitro
13. Description of an in vitro platelet function analyzer PFA-100™
14. Characterization of an in vitro platelet function analyzer PFA-100
15. Preliminary data from the field trial of the PFA-100 system
16. PFA-100 system: A new method for assessment of platelet dysfunction
17. Factors influencing platelet aggregation in the whole blood
18. Flow cytometric measurement of platelet function and reticulated platelets
19. Model of flow cytometer markedly affects platelet-bound P-selectin expression in patients with chest pain. Are we comparing apples with oranges?
20. Measurement of platelet-mediated force development during plasma clot formation
21. Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: Report of a case
22. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100
23. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100)
24. Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents
25. Inhibition of platelet function with ReoPro (abciximab) detected by the platelet function analyzer (PFA-100) in patients undergoing coronary angioplasty (PTCA)